Skip to main content

J&J Scores in a NJ Asbestos Linked Cancer Trial

J&J Scores in a NJ Asbestos Linked Cancer Trial

J&J Scores in a NJ Asbestos Linked Cancer Trial

Introduction

A New Jersey federal court on Thursday cleared Johnson & Johnson of a product liability case filed against it by a plaintiff. The deliberations went on for less than a day in New Brunswick, New Jersey, over allegations that asbestos presence in the company's talcum powder was the reason for her mesothelioma.

J&J faces more than 10,000 product liability cases across the U.S., all with the same assertion that the talcum giant knowingly concealed ovarian cancer and mesothelioma risks associated with its talc products. The company has been charged with cancer lawsuits for several years now. The first trial in April concluded with the jury verdict of $117 million to a man who suffered mesothelioma, and in May J&J was ordered to pay $25.7 million to a woman who was diagnosed with mesothelioma. Both these verdicts are currently under appeal. Four trials after that ended in mistrials as the jury declared a deadlock or because in some cases the plaintiffs passed away before the trial.  In July this year, a Missouri jury declared a massive verdict of $ 4.7 billion favoring 22 women who were diagnosed with ovarian cancer due to asbestos contamination in the talcum powder.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.